The catastrophic hpv/hiv dual viral oncogenomics in concert with dysregulated alternative splicing in cervical cancer

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:2980683 36 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
The catastrophic hpv/hiv dual viral oncogenomics in concert with dysregulated alternative splicing in cervical cancer
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Cervical cancer is a public health problem and has devastating effects in low-to-middle-income countries (LTMICs) such as the sub-Saharan African (SSA) countries. Infection by the human papillomavirus (HPV) is the main cause of cervical cancer. HIV positive women have higher HPV prevalence and cervical cancer incidence than their HIV negative counterparts do. Concurrent HPV/HIV infection is catastrophic, particularly to African women due to the high prevalence of HIV infections. Although various studies show a relationship between HPV, HIV and cervical cancer, there is still a gap in the knowledge concerning the precise nature of this tripartite association. Firstly, most studies show the relationship between HPV and cervical cancer at genomic and epigenetic levels, while the transcriptomic landscape of this relationship remains to be elucidated. Even though many studies have shown HPV/HIV dual viral pathogenesis, the dual molecular oncoviral effects on the development of cervical cancer remains largely uncertain. Furthermore, the effect of highly active antiretroviral therapy (HAART) on the cellular splicing machinery is unclear. Emerging evidence indicates the vital role played by host splicing events in both HPV and HIV infection in the development and progression to cervical cancer. Therefore, decoding the transcriptome landscape of this tripartite relationship holds promising therapeutic potential. This review will focus on the link between cellular splicing machinery, HPV, HIV infection and the aberrant alternative splicing events that take place in HIV/HPV-associated cervical cancer. Finally, we will investigate how these aberrant splicing events can be targeted for the development of new therapeutic strategies against HPV/HIV-associated cervical cancer. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Marima, R.
Hull, R.
Lolas, G.
Syrigos, K.N.
Kgoebane-Maseko, M.
Kaufmann, A.M.
Dlamini, Z.
Περιοδικό:
International Journal of Molecular Sciences
Εκδότης:
MDPI
Τόμος:
22
Αριθμός / τεύχος:
18
Λέξεις-κλειδιά:
messenger RNA, alternative RNA splicing; complication; DNA damage; female; genetics; geography; highly active antiretroviral therapy; human; Human immunodeficiency virus 1; Human immunodeficiency virus infection; incidence; metabolism; Papillomaviridae; papillomavirus infection; pathology; Retroviridae; uterine cervix carcinoma in situ; uterine cervix tumor; virology, Alternative Splicing; Antiretroviral Therapy, Highly Active; Cervical Intraepithelial Neoplasia; DNA Damage; Female; Geography; HIV Infections; HIV-1; Humans; Incidence; Papillomaviridae; Papillomavirus Infections; Retroviridae; RNA, Messenger; Uterine Cervical Neoplasms
Επίσημο URL (Εκδότης):
DOI:
10.3390/ijms221810115
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.